2026 Regulatory Update: On April 15, 2026 the FDA removed both BPC-157 and TB-500 from its Category 2 restricted list
The next generation of research needs to determine which treatment pathways produce the best long-term outcomes, when medications should be introduced, how and when they should be combined with MBS when appropriate, and how we ensure equitable access to effective care. She explains that an important aspect of this new frontier is the changing role of patients themselves
Pairing Dexcom CGM with a GLP-1 At a doctors appointment in 2023, he asked about trying a GLP-1 medication, which his sister had some recent success using
Narrator: Michael has reached his goal weight, yet still works closely with his dietitian and attends regular support groups
Two further points about provenance matter for how the record should be read
They are not one-size-fits-all solutions, and the best starting point depends on the person's goals, health history, medications, and clinician guidance